Patent US5441531A successfully refreshed from Google Patents.
US5441531A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Illuminator and methods for photodynamic therapy
Assignee: Dusa Pharmaceuticals Inc Canada
•
Filing: 1993-10-18
•
Granted: 1995-08-15
•
Expires: 2013-10-18
Abstract
Abstract An illuminator for photodynamic therapy includes a bulb, a condenser lens assembly and a filter assembly. The filter assembly includes the following components in an optical path: (1) a high-pass filter to filter out light having wavelengths below a first wavelength value; (2) a low-pass dichroic filter to filter out light having wavelengths above a second wavelength value; and (3) a dichroic mirror which reflects light having wavelengths between the first wavelength value and the second wavelength value and which transmits infrared light. An exit lens assembly directs light transmitted through the high-pass filter and the low-pass dichroic filter and reflected by the dichroic mirror onto a patient for photodynamic therapy. The condenser lens assembly and the exit lens assembly scramble the beam to ensure that the patient is illuminated with light which is highly uniform in both intensity and spectral characteristics (color) throughout the illuminated area.
Inventors
- 👤 Carlos E. Zarate
- 👤 H.Graciela Zarate
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 20:54
CPC Classifications
A; A61; A61N; A61N5/00; A61N5/06; A61N5/0613; A61N5/062; A61N2005/0635; A61N2005/0642
Claims Analysis
Total Claims: 41
Claim 1
Independent Claim
143 words
A method of photodynamic therapy for a patient to whom has been administered a drug which is activated by light having wavelengths between 600 nanometers and 700 nanometers comprising the step of generating light and performing the following steps (a), (b), (c), and (d), including performing steps (a), (b), and (c) in any order: (a) passing the light through a high-pass filter having a cutoff at a wavelength of about 600 nanometers; (b) passing the light through a low-pass dichroic filter having a cutoff at a wavelength of about 700 nanometers; (c) removing any infrared wavelengths from the light using a dichroic mirror which reflects non-infrared light and which transmits infrared light; and (d) directing light transmitted through the high-pass filter and the low-pass dichroic filter and reflected by the dichroic mirror to the patient as a broadband beam to activate the drug.
Claim 2
Independent Claim
143 words
A method of photodynamic therapy for a patient to whom has been administered a drug which is activated by light having wavelengths between 600 nanometers and 700 nanometers comprising the step of generating light and performing the following steps (a), (b), (c), and (d), including performing steps (a), (b), and (c) in any order: (a) passing the light through a high-pass filter having a cutoff at a wavelength of about 600 nanometers; (b) passing the light through a low-pass dichroic filter having a cutoff at a wavelength of about 700 nanometers; (c) removing any infrared wavelengths from the light using a dichroic mirror which reflects non-infrared light and which transmits infrared light; and (d) directing light transmitted through the high-pass filter and the low-pass dichroic filter and reflected by the dichroic mirror to the patient as a broadband beam to activate the drug.
Claim 3
Dependent Claim
22 words
A method of photodynamic therapy as set forth in claim 1, wherein the light directed to the patient is spatially spectrally uniform.
Claim 4
Dependent Claim
31 words
A method of photodynamic therapy as set forth in claim 1, wherein the light output directed to the patient varies by less than ten percent over a 60 nanometer wavelength range.
Claim 5
Dependent Claim
24 words
A method of photodynamic therapy as set forth in claim 1, wherein the light directed to the patient has a substantially uniform power density.
Claim 6
Dependent Claim
46 words
A method of photodynamic therapy as set forth in claim 4, wherein the light directed to the patient has a power density which varies less than twenty percent over eight-tenths of the diameter of a circle of light on the patient defined by half-maximum intensity points.
Claim 7
Dependent Claim
19 words
A method of photodynamic therapy as set forth in claim 1, further comprising the step of energizing a bulb
Claim 8
Dependent Claim
34 words
A method of photodynamic therapy as set forth in claim 6, wherein the step of energizing the bulb includes energizing a filament and producing an image of the filament parallel and beside the filament.
Claim 9
Dependent Claim
37 words
A method of photodynamic therapy as set forth in claim 1, wherein at half-maximum values the wavelengths of light directed to the patient vary on the order of 0.5% over the area of illumination on the patient.
Claim 10
Dependent Claim
36 words
A method of photodynamic therapy as set forth in claim 1, wherein the distribution of wavelengths of light directed to the patient varies by less than five percent over the area of illumination on the patient.
Claim 11
Independent Claim
141 words
A method of photodynamic therapy comprising the following steps (a), (b), (c), (d), (e), and (f): (a) administering to a patient a drug which is activated by light having wavelengths between about 600 nanometers and about 700 nanometers; (b) energizing a bulb to generate light; (c) passing the light from the bulb through a high-pass filter having a cutoff at a wavelength between 570 nanometers and 630 nanometers; (d) passing the light through a low-pass dichroic filter having a cutoff at a wavelength between 670 nanometers and 730 nanometers; (e) removing any infrared wavelengths from the light using a dichroic mirror which reflects non-infrared light and which transmits infrared light; and (f) directing light transmitted through the high-pass filter and the low-pass dichroic filter and reflected by the dichroic mirror to the patient as a broadband beam to activate the drug.
Claim 12
Independent Claim
141 words
A method of photodynamic therapy comprising the following steps (a), (b), (c), (d), (e), and (f): (a) administering to a patient a drug which is activated by light having wavelengths between about 600 nanometers and about 700 nanometers; (b) energizing a bulb to generate light; (c) passing the light from the bulb through a high-pass filter having a cutoff at a wavelength between 570 nanometers and 630 nanometers; (d) passing the light through a low-pass dichroic filter having a cutoff at a wavelength between 670 nanometers and 730 nanometers; (e) removing any infrared wavelengths from the light using a dichroic mirror which reflects non-infrared light and which transmits infrared light; and (f) directing light transmitted through the high-pass filter and the low-pass dichroic filter and reflected by the dichroic mirror to the patient as a broadband beam to activate the drug.
Claim 13
Dependent Claim
23 words
A method of photodynamic therapy as set forth in claim 10, wherein the light directed to the patient is substantially spatially spectrally uniform.
Claim 14
Dependent Claim
31 words
A method of photodynamic therapy as set forth in claim 10, wherein the light output directed to the patient varies by less than ten percent over a 60 nanometer wavelength range.
Claim 15
Dependent Claim
24 words
A method of photodynamic therapy as set forth in claim 10, wherein the light directed to the patient has a substantially uniform power density.
Claim 16
Dependent Claim
46 words
A method of photodynamic therapy as set forth in claim 13, wherein the light directed to the patient has a power density which varies less than twenty percent over eight-tenths of the diameter of a circle of light on the patient defined by half-maximum intensity points.
Claim 17
Dependent Claim
18 words
A method of photodynamic therapy as set forth in claim 10, wherein the bulb is a tungsten-halogen bulb.
Claim 18
Dependent Claim
37 words
A method of photodynamic therapy as set forth in claim 10, wherein at half-maximum values the wavelengths of light directed to the patient vary on the order of 0.5% over the area of illumination on the patient.
Claim 19
Dependent Claim
34 words
A method of photodynamic therapy as set forth in claim 10, wherein the step of energizing the bulb includes energizing a filament and producing an image of the filament parallel and beside the filament.
Claim 20
Dependent Claim
36 words
A method of photodynamic therapy as set forth in claim 10, wherein the distribution of wavelengths of light directed to the patient varies by less than five percent over the area of illumination on the patient.
Claim 21
Independent Claim
115 words
A method of photodynamic therapy for a patient to whom has been administered a drug which is activated by light, comprising the step of generating light and performing the following steps (a), (b), (c), and (d), including performing steps (a), (b), and (c) in any order: (a) passing the light through a high-pass filter; (b) passing the light through a low-pass dichroic filter; (c) removing any infrared wavelengths from the light using a dichroic mirror which reflects non-infrared light and which transmits infrared light; and (d) directing light transmitted through the high-pass filter and the low-pass dichroic filter and reflected by the dichroic mirror to the patient as a broadband beam to activate the drug.
Claim 22
Independent Claim
115 words
A method of photodynamic therapy for a patient to whom has been administered a drug which is activated by light, comprising the step of generating light and performing the following steps (a), (b), (c), and (d), including performing steps (a), (b), and (c) in any order: (a) passing the light through a high-pass filter; (b) passing the light through a low-pass dichroic filter; (c) removing any infrared wavelengths from the light using a dichroic mirror which reflects non-infrared light and which transmits infrared light; and (d) directing light transmitted through the high-pass filter and the low-pass dichroic filter and reflected by the dichroic mirror to the patient as a broadband beam to activate the drug.
Claim 23
Dependent Claim
23 words
A method of photodynamic therapy as set forth in claim 19, wherein the light directed to the patient is substantially spatially spectrally uniform.
Claim 24
Dependent Claim
31 words
A method of photodynamic therapy as set forth in claim 19, wherein the light output directed to the patient varies by less than ten percent over a 60 nanometer wavelength range.
Claim 25
Dependent Claim
24 words
A method of photodynamic therapy as set forth in claim 19, wherein the light directed to the patient has a substantially uniform power density.
Claim 26
Dependent Claim
46 words
A method of photodynamic therapy as set forth in claim 22, wherein the light directed to the patient has a power density which varies less than twenty percent over eight-tenths of the diameter of a circle of light on the patient defined by half-maximum intensity points.
Claim 27
Dependent Claim
19 words
A method of photodynamic therapy as set forth in claim 19, further comprising the step of energizing a bulb.
Claim 28
Dependent Claim
34 words
A method of photodynamic therapy as set forth in claim 24, wherein the step of energizing the bulb includes energizing a filament and producing an image of the filament parallel and beside the filament.
Claim 29
Dependent Claim
37 words
A method of photodynamic therapy as set forth in claim 19, wherein at half-maximum values the wavelengths of light directed to the patient vary on the order of 0.5% over the area of illumination on the patient.
Claim 30
Dependent Claim
36 words
A method of photodynamic therapy as set forth in claim 19, wherein the distribution of wavelengths of light directed to the patient varies by less than five percent over the area of illumination on the patient.
Claim 31
Independent Claim
133 words
A method of photodynamic therapy for a patient to whom has been administered a drug which is activated by light, comprising the step of generating light and performing the following steps (a), (b), (c), and (d), including performing steps (a), (b), and (c) in any order: (a) passing the light through a high-pass filter; (b) passing the light through a low-pass dichroic filter; (c) removing any infrared wavelengths from the light using a dichroic mirror which reflects non-infrared light and which transmits infrared light; and (d) directing light transmitted through the high-pass filter and the low-pass dichroic filter and reflected by the dichroic mirror to the patient as a broadband beam to activate the drug, the light directed to the patient being almost entirely in the 600 nanometer to 700 nanometer wavelength range.
Claim 32
Independent Claim
133 words
A method of photodynamic therapy for a patient to whom has been administered a drug which is activated by light, comprising the step of generating light and performing the following steps (a), (b), (c), and (d), including performing steps (a), (b), and (c) in any order: (a) passing the light through a high-pass filter; (b) passing the light through a low-pass dichroic filter; (c) removing any infrared wavelengths from the light using a dichroic mirror which reflects non-infrared light and which transmits infrared light; and (d) directing light transmitted through the high-pass filter and the low-pass dichroic filter and reflected by the dichroic mirror to the patient as a broadband beam to activate the drug, the light directed to the patient being almost entirely in the 600 nanometer to 700 nanometer wavelength range.
Claim 33
Dependent Claim
19 words
A method of photodynamic therapy as set forth in claim 28, further comprising the step of energizing a bulb.
Claim 34
Independent Claim
134 words
A method of photodynamic therapy comprising the following steps (a), (b), (c), (d), (e), and (f): (a) administering to a patient a drug which is activated by light having wavelengths between about 600 nanometers and about 700 nanometers; (b) generating light; (c) passing the light through a high-pass filter having a cutoff at a wavelength between 570 nanometers and 630 nanometers; (d) passing the light through a low-pass dichroic filter having a cutoff at a wavelength between 670 nanometers and 730 nanometers; (e) removing any infrared wavelengths from the light using a dichroic mirror which reflects non-infrared light and which transmits infrared light; and (f) directing light transmitted through the high-pass filter and the low-pass dichroic filter and reflected by the dichroic mirror to the patient as a broadband beam to activate the drug.
Claim 35
Independent Claim
134 words
A method of photodynamic therapy comprising the following steps (a), (b), (c), (d), (e), and (f): (a) administering to a patient a drug which is activated by light having wavelengths between about 600 nanometers and about 700 nanometers; (b) generating light; (c) passing the light through a high-pass filter having a cutoff at a wavelength between 570 nanometers and 630 nanometers; (d) passing the light through a low-pass dichroic filter having a cutoff at a wavelength between 670 nanometers and 730 nanometers; (e) removing any infrared wavelengths from the light using a dichroic mirror which reflects non-infrared light and which transmits infrared light; and (f) directing light transmitted through the high-pass filter and the low-pass dichroic filter and reflected by the dichroic mirror to the patient as a broadband beam to activate the drug.
Claim 36
Independent Claim
141 words
A method of photodynamic therapy comprising the following steps (a), (b), (c), (d), (e), and (f): (a) administering to a patient a drug which is activated by light having wavelengths between about 600 nanometers and about 700 nanometers; (b) energizing a bulb to generate light; (c) passing the light from the bulb through a high-pass filter having a cutoff at a wavelength between 570 nanometers and 700 nanometers; (d) passing the light through a low-pass dichroic filter having a cutoff at a wavelength between 600 nanometers and 730 nanometers; (e) removing any infrared wavelengths from the light using a dichroic mirror which reflects non-infrared light and which transmits infrared light; and (f) directing light transmitted through the high-pass filter and the low-pass dichroic filter and reflected by the dichroic mirror to the patient as a broadband beam to activate the drug.
Claim 37
Independent Claim
141 words
A method of photodynamic therapy comprising the following steps (a), (b), (c), (d), (e), and (f): (a) administering to a patient a drug which is activated by light having wavelengths between about 600 nanometers and about 700 nanometers; (b) energizing a bulb to generate light; (c) passing the light from the bulb through a high-pass filter having a cutoff at a wavelength between 570 nanometers and 700 nanometers; (d) passing the light through a low-pass dichroic filter having a cutoff at a wavelength between 600 nanometers and 730 nanometers; (e) removing any infrared wavelengths from the light using a dichroic mirror which reflects non-infrared light and which transmits infrared light; and (f) directing light transmitted through the high-pass filter and the low-pass dichroic filter and reflected by the dichroic mirror to the patient as a broadband beam to activate the drug.
Claim 38
Dependent Claim
23 words
A method of photodynamic therapy as set forth in claim 31, wherein the light directed to the patient is substantially spatially spectrally uniform.
Claim 39
Dependent Claim
23 words
A method of photodynamic therapy as set forth in claim 31, Wherein the light directed to the patient has a uniform power density.
Claim 40
Dependent Claim
37 words
A method of photodynamic therapy as set forth in claim 31, wherein at half-maximum values the wavelengths of light directed to the patient vary on the order of 0.5% over the area of illumination on the patient.
Claim 41
Dependent Claim
36 words
A method of photodynamic therapy as set forth in claim 31, wherein the distribution of wavelengths of light directed to the patient varies by less than five percent over the area of illumination on the patient.
References Cited (Backward Citations)
US3711700A
Cited
US4336809A
Cited
US4316467A
Cited
GB2100403A
Cited
US4686986A
Cited
US4562831A
Cited
US4932934A
Cited
US4573467A
Cited
US4690141A
Cited
US4836203A
Cited
EP0253734A1
Cited
US4822335A
Cited
US4933816A
Cited
US4957481A
Cited
US5010452A
Cited
US4951663A
Cited
WO1989011260A1
Cited
US5079262A
Cited
US5211938A
Cited
US5211938B1
Cited
US5174297A
Cited
US5071416A
Cited
EP0478506A2
Cited
DE4112275A1
Cited
US5344434A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-08-14 | 1999-02-13 | 1999-08-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-08-14 | 2003-02-13 | 2003-08-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-08-14 | 2007-02-13 | 2007-08-15 | $7700.00 | Window Closed / Lapsed |